NEW DELHI: Indian Space Research Organisation (ISRO) chairman, S Somanath, recently disclosed that he had been diagnosed with cancer on the day of the launch of India’s Aditya L1 solar mission. In an interview with Tarmak Media House, Somanath shared that he underwent surgery and chemotherapy, and he is now completely cured of the disease.
“I am completely healthy now,” Somanath said, saying that he has successfully overcome the health challenge. He acknowledged experiencing some health issues during the Chandrayaan-3 mission launch last year but wasn’t initially clear about them. It was during a scan on the day of the Aditya L-1 launch that he received a clue about his condition.
“After the launch, I underwent further tests in Chennai, confirming the presence of a cancerous growth in my large intestine. Following this diagnosis, I underwent surgery and chemotherapy,” shared the ISRO Chairman.
Despite the initial uncertainty, Somanath sought advice from family members who had faced similar challenges, helping him cope with the situation. He acknowledged the shock his family might have experienced initially but emphasized that cancer, with advancements in treatment, is not incurable.
“I was uncertain about complete cure at the time I was undergoing the process,” admitted Somanath, emphasizing the nature of his battle against cancer. He expressed gratitude for the support from his family and revealed that he would continue to undergo regular check-ups and scans, having resumed his duties after the successful recovery.
Somanath’s resilience and return to his responsibilities amid the diagnosis and treatment showcase his dedication to ISRO’s mission even during personal challenges.
“I am completely healthy now,” Somanath said, saying that he has successfully overcome the health challenge. He acknowledged experiencing some health issues during the Chandrayaan-3 mission launch last year but wasn’t initially clear about them. It was during a scan on the day of the Aditya L-1 launch that he received a clue about his condition.
“After the launch, I underwent further tests in Chennai, confirming the presence of a cancerous growth in my large intestine. Following this diagnosis, I underwent surgery and chemotherapy,” shared the ISRO Chairman.
Despite the initial uncertainty, Somanath sought advice from family members who had faced similar challenges, helping him cope with the situation. He acknowledged the shock his family might have experienced initially but emphasized that cancer, with advancements in treatment, is not incurable.
“I was uncertain about complete cure at the time I was undergoing the process,” admitted Somanath, emphasizing the nature of his battle against cancer. He expressed gratitude for the support from his family and revealed that he would continue to undergo regular check-ups and scans, having resumed his duties after the successful recovery.
Somanath’s resilience and return to his responsibilities amid the diagnosis and treatment showcase his dedication to ISRO’s mission even during personal challenges.
